{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-095847","form_type":"8-K","ticker":"ONCO","cik":"0001782107","company_name":"Onconetix, Inc.","filed_at":"2025-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.436838+00:00","generated_at":"2026-05-17T04:48:24.977130+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Onconetix secures $6.25M through PIPE of Series E convertible preferred and warrants","bullets":["Sold 7,813 shares of Series E convertible preferred stock at $1,000 stated value per share.","Series E convertible at $3.8576 per share; warrants to purchase 2,025,223 common shares included.","Total gross proceeds of approximately $6.25 million from institutional investors.","Ownership limitation set at 4.99%; registration rights agreement granted for underlying shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-095847","json":"https://secwatch.observer/filing/0001213900-25-095847.json","markdown":"https://secwatch.observer/filing/0001213900-25-095847.md","text":"https://secwatch.observer/filing/0001213900-25-095847.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025095847/0001213900-25-095847-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025095847/ea0259860-8k_onconetix.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:48:24.977130+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"82b7188a7bf9c7aa8a6488d81e243c87787ad65f","claim":"Onconetix, Inc. issued warrants to purchase 2,025,223 shares of Common Stock of warrant to institutional investors for aggregate purchase price of approximately $6.25 million.","evidence_excerpt":"On October 1, 2025, Onconetix, Inc., a Delaware corporation (the “ Company ”), entered into, and sold to institutional investor(s) (collectively, the “ PIPE Investors ”), pursuant to a securities purchase agreement (the “ Securities Purchase Agreement ”) an aggregate of 7,813 shares of Series E convertible preferred stock, par value $0.00001 per share (“ Series E Preferred Stock ”), which are convertible into common stock of the Company, $0.00001 par value per share (the “ Common Stock ”) and warrants to purchase 2,025,223 shares of Common Stock (the “ Warrants ” and, together with the Series E Preferred Stock, the “ PIPE Securities ”), for an aggregate purchase price of approximately $6.25 million.","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025095847/0001213900-25-095847-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"warrants to purchase 2,025,223 shares of Common Stock"},{"label":"Purchaser","value":"institutional investors"},{"label":"Consideration","value":"aggregate purchase price of approximately $6.25 million"}],"fact_type":"equity_issuance"},{"claim_id":"f3f54d7bb526dba407a29fd1f6025fd856007c83","claim":"Onconetix, Inc. issued 7,813 shares of Series E convertible preferred stock of preferred stock to institutional investors for aggregate purchase price of approximately $6.25 million.","evidence_excerpt":"On October 1, 2025, Onconetix, Inc., a Delaware corporation (the “ Company ”), entered into, and sold to institutional investor(s) (collectively, the “ PIPE Investors ”), pursuant to a securities purchase agreement (the “ Securities Purchase Agreement ”) an aggregate of 7,813 shares of Series E convertible preferred stock, par value $0.00001 per share (“ Series E Preferred Stock ”), which are convertible into common stock of the Company, $0.00001 par value per share (the “ Common Stock ”) and warrants to purchase 2,025,223 shares of Common Stock (the “ Warrants ” and, together with the Series E Preferred Stock, the “ PIPE Securities ”), for an aggregate purchase price of approximately $6.25 million.","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025095847/0001213900-25-095847-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"preferred stock"},{"label":"Shares","value":"7,813 shares of Series E convertible preferred stock"},{"label":"Purchaser","value":"institutional investors"},{"label":"Consideration","value":"aggregate purchase price of approximately $6.25 million"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}